Efficacy and Safety of Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Moderate to Severe Plaque Psoriasis of the Lower Extremities

Main Article Content

SK Tyring
LH Kircik
PS Yamauchi
N Anbalagan
T Lin


Halobetasol, Tazarotene, Psoriasis, Lower Extremities


Abstract not available.


1. Nestle FO, et al. N Engl J Med. 2009;361(5):496‑509.
2. Augustin M, et al. Br J Dermatol. 2019;181(2):358-365.
3. Lam LH, et al. J Drugs Dermatol. 2016;15(8):945‑948.
4. Stein Gold L, et al. J Am Acad Dermatol. 2018;79(2):287-293.
5. Sugarman JL, et al. J Drugs Dermatol. 2018;17(8):855‑861.

Most read articles by the same author(s)